Showing results (151-160 of 211) with videos related to
Sort By:
Pageof 22
Nature Communications|November 19, 2014
Evidence for henipavirus spillover into human populations in AfricaOlivier Pernet, Bradley S Schneider, Shannon M Beaty, et al.The Journal of Infectious Diseases|June 19, 2018
Experimental Infection of Syrian Hamsters With Aerosolized Nipah VirusOlivier Escaffre, Terence Hill, Tetsuro Ikegami, et al.Proceedings of the National Academy of Sciences of the United States of America|November 27, 2019
A structural basis for antibody-mediated neutralization of Nipah virus reveals a site of vulnerability at the fusion glycoprotein apexVictoria A Avanzato, Kasopefoluwa Y Oguntuyo, Marina Escalera-Zamudio, et al.Iscience|November 21, 2022
Immune profiles to distinguish hospitalized versus ambulatory COVID-19 cases in older patientsJéromine Klingler, Gregory S Lambert, Juan C Bandres, et al.AIDS Research and Human Retroviruses|August 12, 2017
Analysis of Clinical HIV-1 Strains with Resistance to Maraviroc Reveals Strain-Specific Resistance Mutations, Variable Degrees of Resistance, and Minimal Cross-Resistance to Other CCR5 AntagonistsJacqueline K Flynn, Paula Ellenberg, Renee Duncan, et al.Plos Pathogens|December 10, 2015
Crystal Structure of the Pre-fusion Nipah Virus Fusion Glycoprotein Reveals a Novel Hexamer-of-Trimers AssemblyKai Xu, Yee-Peng Chan, Birgit Bradel-Tretheway, et al.Virology|April 23, 2013
The magnitude of HIV-1 resistance to the CCR5 antagonist maraviroc may impart a differential alteration in HIV-1 tropism for macrophages and T-cell subsetsJacqueline K Flynn, Geza Paukovics, Miranda S Moore, et al.Journal of Virology|December 28, 2012
Transmitted/founder and chronic HIV-1 envelope proteins are distinguished by differential utilization of CCR5Zahra F Parker, Shilpa S Iyer, Craig B Wilen, et al.Journal of Virology|September 6, 2024
A monoclonal antibody targeting the Nipah virus fusion glycoprotein apex imparts protection from diseaseVictoria A Avanzato, Trenton Bushmaker, Kasopefoluwa Y Oguntuyo, et al.Acta Pharmaceutica Sinica. B|March 7, 2022
Suppressing fatty acid synthase by type I interferon and chemical inhibitors as a broad spectrum anti-viral strategy against SARS-CoV-2Saba R Aliyari, Amir Ali Ghaffari, Olivier Pernet, et al.Pageof 22